- Conditions
- Carcinoma, Epithelial Tumors, Malignant, Malignant Solid Tumor, +3 more
- Locations
-
- Vall d'Hebron Institute of Oncology Barcelona, Spain
Clinical trial condition
Malignant Solid Tumor
Explore clinical trials studying Malignant Solid Tumor. Study availability and eligibility vary by location and protocol.
38 public trials
11 recruiting studies
Malignant Solid Tumor trial results
Enrolling by invitation
Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid Tumors
NCT07741006
- Conditions
- Malignant Solid Tumor
- Locations
-
- Union Hospital, Huazhong University of Science and Technology Wuhan, Hubei, China
Active, not recruiting
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
NCT06057038
- Conditions
- Malignant Solid Tumor
- Locations
-
- National Cancer Center East Kashiwa, Japan
- National Cancer Center Hospital Tokyo, Japan
- Tokyo Medical University Hospital Tokyo, Japan
Active, not recruiting
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
- Locations
-
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Cancer & Blood Specialty Clinic Los Alamitos, California, United States
- Moores Cancer Center at the UC San Diego Health San Diego, California, United States
- Yale University Cancer Center New Haven, Connecticut, United States
Active, not recruiting
A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT04632108
- Conditions
- Malignant Solid Tumor
- Locations
-
- Beijing cancer hospital Beijing, Beijing Municipality, China
- Linyi cancer hospital Linyi, Shandong, China
NCT07639905
- Conditions
- Malignant Solid Tumor
- Locations
-
- The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
NCT05727839
- Conditions
- Cutaneous Tumor, Malignant Solid Tumor, Neoplasms, +4 more
- Locations
-
- The George Washington Medical Faculty Associates Washington D.C., District of Columbia, United States
- Sun Yat-sen University Cancer Center Guangdong, Guangzhou, China
Completed
A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies
NCT03834662
- Conditions
- Malignant Solid Tumor
- Locations
-
- START Midwest Clinic Grand Rapids, Michigan, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Princess Margaret Cancer Centre Toronto, Canada
NCT01359982
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Moores University of California San Diego Cancer Center La Jolla, California, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Conditions
- Malignant Solid Tumor
- Locations
-
- The University of Kansas Clinical Research Center Site Number : 8400004 Fairway, Kansas, United States
- Massachusetts General Hospital Site Number : 8400001 Boston, Massachusetts, United States
- Dana Farber Cancer Institute Site Number : 8400101 Boston, Massachusetts, United States
- Duke University Medical Center Site Number : 8400008 Durham, North Carolina, United States